Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blinded, Parallel Group Comparison Study of the Safety and Efficacy of UHE-103 in Subjects With Moccasin-Type Tinea Pedis
Conditions
Interventions
UHE-103A1 cream
UHE-103A2 cream
+3 more
Locations
12
United States
Site 03
San Diego, California, United States
Site 12
Melbourne, Florida, United States
Site 06
Miami, Florida, United States
Site 09
North Miami Beach, Florida, United States
Site 07
Rolling Meadows, Illinois, United States
Site 11
Fridley, Minnesota, United States
Start Date
March 15, 2019
Primary Completion Date
October 21, 2019
Completion Date
May 5, 2020
Last Updated
October 28, 2021
NCT07245667
NCT00233493
NCT03129321
NCT01891305
NCT03135912
NCT02606383
Lead Sponsor
Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions